You are invited to join Paul Schulz, MD, for a previously recorded live educational webinar on the latest treatment advances for dementia and Alzheimer’s disease.

Dr. Schulz is a professor and Director of the Memory Disorders and Dementia Clinic in the Department of Neurology at McGovern Medical School at UTHealth Houston. He is fellowship trained in cellular neurophysiology.

A UTHealth Neurosciences physician affiliated with Mischer Neuroscience Institute, he is currently investigating risk factors for dementia and is utilizing Aduhelm™ (aducanumab-avwa), the promising new treatment option for Alzheimer’s disease, in his patients’ treatment plans, when appropriate.

Dr. Schulz will discuss Aduhelm™, the newest Alzheimer’s disease drug in over 20 years.

During the webinar, you will learn more about:

  • What are dementia and Alzheimer’s disease
  • Signs and symptoms of dementia and Alzheimer’s disease, and how to know the difference
  • New treatment option Aduhelm™ —the first FDA -approved drug that affects the course of Alzheimer’s disease

During the webinar, you will get answers relating to:

  • Other approaches to treating Alzheimer’s disease
  • Insurance coverage for testing
  • Qualifications for this new medication

Contact Us

Please fill out the fields below, and we will contact you.


Thank you for contacting Memorial Hermann. We have received your inquiry, and a team member will contact you soon.

If you need more immediate assistance, please call us at (713) 222-CARE.

If you are experiencing a medical emergency, call 911 or go to the nearest emergency room.